OTCM
QURT
Market cap9mUSD
Feb 21, Last price
0.60USD
Name
Quarta-Rad Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Quarta-Rad, Inc. specializes in the distribution and sale of various detection instruments, serving homeowners, building contractors, and home renovation specialists across North America, Europe, and Asia. The company's product line includes a comprehensive range of radiation monitoring equipment. Among these are several handheld radiation detectors for the consumer market, such as the RADEX RD1503 and RD1212. Other notable devices include the RADEX RD1706 (a general-purpose handheld detector), the RADEX RD1008 (which measures Gamma- and Beta-radiation), the RADEX RD1212-BT (a handheld unit with Bluetooth connectivity), and the compact, personal RADEX RD ONE. Beyond radiation, Quarta-Rad also provides the RADEX M107, an accessible radon gas detector that issues visual and auditory alerts when predefined thresholds are met. Additionally, they offer the RADEX EMI50, a portable device designed for real-time assessment of both electric field strength and electromagnetic fields. Furthermore, their inventory extends to light and brightness detection tools. An example is the RADEX Lupin, a handheld instrument capable of evaluating illumination levels, brightness, and the flicker ratio specifically on LED screens. Quarta-Rad markets its products through a network of independent distributors and via its online sales platforms. The company, initially incorporated in 2011, was first known as Quatra-Rad, Inc. before officially rebranding to Quarta-Rad, Inc. in February 2012. Its headquarters are located in Wilmington, Delaware.
Key people
Victor Shvetsky
Chairman of the Board, Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer, Secretary · since 2011
Alexey Golovanov
President, Director · since 2011
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||